Skip to main content
ClinicalTrials.govclosed

Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI

ClinicalTrials.gov study NCT03933761. IPD Sharing: NO. Countries: 0. Publications: 0.

ShareScore

20/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship
8
Harmonization
8
Access
0
Reuse readiness
0
Engagement
4

Topics